Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas

Hormone and Metabolic Research

Volumn 30, Issue 10, 1998, Pages 619-623

  Ilvesmaki V ^a,c   Liu, J ^a   Heikkila P ^a   Kahri, A I ^a   Voutilainen, R ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adrenal; Adrenocortical; IGFBP; Insulin Like Growth Factor Binding Protein; Pheochromocytoma

Indexed keywords

MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN;

ADRENAL CORTEX TUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; PATHOGENESIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 0031756416     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978945     Document Type: Article

References (33)

1. Rechler MM, Nissley SP. Insulin like growth factors. In: Sporn MB, Roberts AB (eds): Peptide Growth Factors and Their Receptors I. New York: Springer-Verlag, 1991: 263-367
2. Cohick WS, Clemmons DR. The insulin-like growth factors. Ann Rev Physiol 1993; 55: 131-53
3. Daughaday WH. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 1990; 127: 1-4
4. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311-20
5. Feige J-J, Baird A. Growth factor regulation of adrenal cortex growth and function. Prog Growth Factor Res 1991; 3: 103-13
6. Weber MM, Simmler P, Fottner C, Engelhardt D. Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating cortisol secretion from cultured bovine adrenocortical cells: interaction with the IGF-I receptor and IGF-binding proteins. Endocrinology 1995; 136: 3714-20
7. Voutilainen R, Miller WL. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc, in human steroidogenic tissues. Proc Natl Acad Sci 1987; 84: 1590-4
8. Ilvesmäki V, Blum WF, Voutilainen R. Insulin-like growth factor-II in human fetal adrenals: regulation by ACTH, protein kinase C and growth factors. J Endocrinol 1993; 137: 533-42
9. Mesiano S, Mellon SH, Jaffe RB. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 1993; 76: 968-76
10. Voutilainen R, Miller WL. Developmental and hormonal regulation of mRNAs for insulin-like growth factor II and steroidogenic enzymes in human fetal adrenals and gonads. DNA 1988; 7: 9-15
11. Ilvesmäki V, Kahri AI, Miettinen PJ, Voutilainen R. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metab 1993; 77: 852-8
12. Gicquel C, Bertagna X, Schneid H, Francillard-Leblond M, Luton J-P, Girard F, Le Bouc Y. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab 1994; 78: 1444-53
13. Liu J, Kahri AL, Heikkilä P, Ilvesmäki V, Voutilainen R. H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 1995; 80: 492-6
14. Haselbacher GK, Irminger JC, Zapf J, Ziegler WH, Humbel RE. Insulin-like growth factor 11 in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. Proc Natl Acad Sci USA 1987; 84: 1104-6
15. Liu J, Kahri AI, Heikkilä P, Blum WF, Voutilainen R. Glucocorticoids increase insulin-like growth factor-II mRNA accumulation in cultured human pheochromocytoma cells. J Endocrinol 1994; 142: 29-35
16. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 1995; 16: 3-33
17. Oh Y, Nagalla SR, Yamanaka Y, Kim H-S, Wilson E, Rosenfeld EG. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. J Biol Chem 1996; 271: 30322-5
18. Rechler MM. Editorial: Growth inhibition by insulin-like growth factor (IGF) binding protein-3-what's IGF got to do with it? Endocrinology 1997; 138: 2645-7
19. Ilvesmäki V, Blum WF, Voutilainen R. Insulin-like growth factor binding proteins in human adrenal gland. Mol Cell Endocrinol 1993; 97: 71-9
20. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9
21. Ilvesmäki V, Voutilainen R. Interaction of phorbol ester and adrenocorticotropin in the regulation of steroidogenic P450 genes in human fetal and adult adrenal cell cultures. Endocrinology 1991; 128: 1450-8
22. Arnheim N. Characterization of mouse ribosomal gene fragments purified by molecular cloning. Gene 1979; 7: 83-96
23. Bell GI, Merryweather JP, Sanchez-Pescador R, Stempien MM, Priestley L, Scott J, Rall LB. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984; 310: 775-7
24. Hintz RL, Bock S, Thorsson AV, Bovens J, Powell DR, Jakse G, Petrides PE. Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas. J Urol 1991; 146: 1160-3
25. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J Clin Endocrinol Metab 1996; 81: 411-20
26. Karasik A, Menczer J, Pariente C, Kanety H. Insulin-like growth factor-I (IGF-1) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol 1994; 78: 271-6
27. Schwander J, Mary JL. The RIA for IGFBP-2 in man - a meagre catch? Growth Regul 1993; 3: 104-8
28. El Atiq F, Garrouste F, Remacle-Bonnet M, Sastre B, Pommier G. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor binding proteins in patients with colorectal cancer. Int J Cancer 1994; 57: 491-7
29. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 1996; 88: 601-6
30. van der Ven LTM, van Buul-Offers SC, Gloudemans T, Bloemen RJ, Roholl PJM, Sussenbach JS, den Otter W. Modulation of insulin-like growth factor (IGF) action by IGF-binding proteins in normal, benign, and malignant smooth muscle tissues. J Clin Endocrinol Metab 1996; 81: 3629-35
31. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 1993; 77: 229-33
32. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 1997; 82: 2308-13
33. Bang P, Degerblad M, Thorén M, Schwander J, Blum W, Hall K. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome. Acta Endocrinol 1993; 128; 397-404